Role of endothelin in microvascular dysfunction following percutaneous coronary intervention for nonST elevation myocardial infarction

Trial Profile

Role of endothelin in microvascular dysfunction following percutaneous coronary intervention for nonST elevation myocardial infarction

Completed
Phase of Trial: Phase II

Latest Information Update: 14 Jun 2012

At a glance

  • Drugs PMZ-2123 (Primary)
  • Indications Myocardial infarction
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 14 Jun 2012 Actual patient number is 24 according to ClinicalTrials.gov.
    • 14 Jun 2012 Actual end date (Jan 2012) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top